| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.61e-12 | 67 | 163 | 11 | GO:0031492 |
| GeneOntologyMolecularFunction | nucleosome binding | H2AC11 H2AZ2 H2AC21 PARP1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.58e-11 | 98 | 163 | 12 | GO:0031491 |
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.78e-10 | 100 | 163 | 11 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2AC11 SUPT3H H2AZ2 RALGAPB H2AC21 RALGAPA2 TENM2 H2AC6 H2AC4 H2AC1 TENM1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 4.67e-09 | 398 | 163 | 18 | GO:0046982 |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 2.13e-08 | 5 | 163 | 4 | GO:0035731 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.29e-07 | 167 | 163 | 11 | GO:0031490 |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.47e-07 | 7 | 163 | 4 | GO:0004769 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.49e-07 | 33 | 163 | 6 | GO:0005217 | |
| GeneOntologyMolecularFunction | protein dimerization activity | MAG H2AC11 SUPT3H H2AZ2 RALGAPB H2AC21 TSG101 RALGAPA2 TERT TENM2 PTPRT MAP3K5 GSTA1 GSTA2 GSTA3 PARP1 H2AC6 H2AC4 H2AC1 GSTA5 TENM1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 4.85e-07 | 1205 | 163 | 28 | GO:0046983 |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 5.34e-07 | 3 | 163 | 3 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 5.34e-07 | 3 | 163 | 3 | GO:0004117 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | ASIC2 ASIC1 PKD2L1 GRID2 RYR2 RYR3 ITPR1 ITPR3 CNGA2 CNGA3 GABRR3 | 5.52e-07 | 193 | 163 | 11 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | ASIC2 ASIC1 PKD2L1 GRID2 RYR2 RYR3 ITPR1 ITPR3 CNGA2 CNGA3 GABRR3 | 6.77e-07 | 197 | 163 | 11 | GO:0022834 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.27e-06 | 140 | 163 | 9 | GO:0099094 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 2.88e-06 | 28 | 163 | 5 | GO:0004602 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ASIC2 ASIC1 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 RYR2 RYR3 ITPR1 ITPR3 SCN10A CNGA2 CNGA3 GABRR3 | 5.64e-06 | 459 | 163 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.10e-05 | 129 | 163 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.20e-05 | 18 | 163 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | glutathione binding | 1.20e-05 | 18 | 163 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 1.51e-05 | 19 | 163 | 4 | GO:0016863 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.87e-05 | 20 | 163 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | gated channel activity | ASIC2 ASIC1 PKD2L1 GRID2 RYR2 RYR3 ITPR1 ITPR3 SCN10A CNGA2 CNGA3 GABRR3 | 2.00e-05 | 334 | 163 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ASIC2 ASIC1 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 GABRR3 | 2.66e-05 | 793 | 163 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | ASIC2 ASIC1 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 RYR2 RYR3 ITPR1 ITPR3 SCN10A CNGA2 CNGA3 GABRR3 | 2.74e-05 | 525 | 163 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ASIC2 ASIC1 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 RYR2 RYR3 ITPR1 ITPR3 SCN10A CNGA2 CNGA3 GABRR3 | 2.80e-05 | 526 | 163 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ASIC2 ASIC1 PKD2L1 SLC24A3 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A CNGA2 CNGA3 | 2.91e-05 | 465 | 163 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.43e-05 | 151 | 163 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.50e-05 | 52 | 163 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK2 DOCK4 RASGRP4 SGSM1 RALGAPB DEPDC1 RALGAPA2 ARHGAP1 RASGRP1 NF1 ARHGAP31 FGD6 SOS1 SOS2 | 7.38e-05 | 507 | 163 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK2 DOCK4 RASGRP4 SGSM1 RALGAPB DEPDC1 RALGAPA2 ARHGAP1 RASGRP1 NF1 ARHGAP31 FGD6 SOS1 SOS2 | 7.38e-05 | 507 | 163 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.27e-05 | 171 | 163 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 8.67e-05 | 29 | 163 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK2 DOCK4 SGSM1 RALGAPB DEPDC1 RALGAPA2 ARHGAP1 NF1 ARHGAP31 SOS1 | 1.02e-04 | 279 | 163 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.13e-04 | 31 | 163 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | ASIC2 ASIC1 PKD2L1 SLC24A3 RYR2 RYR3 ITPR1 ITPR3 SCN10A CNGA2 CNGA3 | 1.23e-04 | 343 | 163 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 RASGRP4 PCDHGA9 PCDHGA7 PCLO PKD2L1 ADGRV1 LCP1 TENM2 RYR2 RYR3 ITPR1 ITPR3 RASGRP1 PCDHGA12 DNASE1L2 PADI3 | 1.39e-04 | 749 | 163 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ASIC2 ASIC1 PKD2L1 SLC24A3 APOL1 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 GABRR3 | 1.60e-04 | 758 | 163 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 1.76e-04 | 64 | 163 | 5 | GO:0016765 | |
| GeneOntologyMolecularFunction | peroxidase activity | 1.90e-04 | 65 | 163 | 5 | GO:0004601 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.98e-04 | 3 | 163 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ASIC2 ASIC1 PKD2L1 SLC24A3 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 | 1.99e-04 | 627 | 163 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on peroxide as acceptor | 2.19e-04 | 67 | 163 | 5 | GO:0016684 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ASIC2 ASIC1 PKD2L1 SLC24A3 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 | 3.66e-04 | 664 | 163 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.93e-04 | 4 | 163 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 7.34e-04 | 22 | 163 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 ASIC2 ASIC1 ABCA12 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 ATP9A RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 GABRR3 | 8.14e-04 | 1289 | 163 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 9.53e-04 | 24 | 163 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.72e-04 | 6 | 163 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.08e-03 | 25 | 163 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.17e-03 | 254 | 163 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | antioxidant activity | 1.20e-03 | 97 | 163 | 5 | GO:0016209 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 1.21e-03 | 57 | 163 | 4 | GO:0016860 | |
| GeneOntologyMolecularFunction | lipid binding | NPC1 MAG RASGRP4 PCLO APOL1 GSTA1 GSTA2 GSTA3 ITPR1 ITPR3 RASGRP1 SNX14 NF1 AP2A2 GSTA5 C8G HSPA8 PRLR | 1.21e-03 | 988 | 163 | 18 | GO:0008289 |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.35e-03 | 27 | 163 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 1.35e-03 | 7 | 163 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.35e-03 | 7 | 163 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ASIC2 ASIC1 ABCA12 TPTE2 PKD2L1 SLC24A3 GRID2 APOL1 RYR2 RYR3 ITPR1 ITPR3 SLC9A5 SLC12A9 SLC6A5 SCN10A SLC45A1 CNGA2 CNGA3 GABRR3 | 1.55e-03 | 1180 | 163 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 2.03e-03 | 31 | 163 | 3 | GO:0022839 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.45e-03 | 69 | 163 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 2.85e-03 | 10 | 163 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.94e-03 | 231 | 163 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 3.28e-03 | 122 | 163 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.54e-03 | 239 | 163 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.93e-03 | 39 | 163 | 3 | GO:0030551 | |
| GeneOntologyMolecularFunction | metal cluster binding | 4.77e-03 | 83 | 163 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 4.87e-03 | 13 | 163 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 4.87e-03 | 13 | 163 | 2 | GO:0043855 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 TDRD12 | 5.43e-10 | 163 | 162 | 13 | GO:0031507 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 TDRD12 | 7.94e-09 | 203 | 162 | 13 | GO:0045814 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 TDRD12 | 2.18e-06 | 330 | 162 | 13 | GO:0040029 |
| GeneOntologyBiologicalProcess | sensory perception of sour taste | 3.86e-05 | 9 | 162 | 3 | GO:0050915 | |
| GeneOntologyCellularComponent | nucleosome | H2AC11 H2AZ2 H2AC21 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.29e-08 | 138 | 165 | 11 | GO:0000786 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.01e-05 | 88 | 165 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.92e-04 | 114 | 165 | 6 | GO:0016528 | |
| HumanPheno | Neoplasm of the breast | 3.02e-05 | 92 | 51 | 7 | HP:0100013 | |
| HumanPheno | Absent sperm axoneme central pair complex | 3.22e-05 | 7 | 51 | 3 | HP:0033525 | |
| HumanPheno | Abnormal sperm axoneme morphology | 5.11e-05 | 8 | 51 | 3 | HP:0033524 | |
| Domain | HISTONE_H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.20e-18 | 21 | 163 | 11 | PS00046 |
| Domain | Histone_H2A_CS | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.61e-18 | 15 | 163 | 10 | IPR032458 |
| Domain | Histone_H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.96e-17 | 23 | 163 | 11 | IPR002119 |
| Domain | H2A | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.96e-17 | 23 | 163 | 11 | SM00414 |
| Domain | Histone_H2A_C | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.58e-17 | 17 | 163 | 10 | IPR032454 |
| Domain | Histone_H2A_C | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.58e-17 | 17 | 163 | 10 | PF16211 |
| Domain | Histone_H2A/H2B/H3 | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 1.43e-15 | 56 | 163 | 13 | IPR007125 |
| Domain | Histone | H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 1.43e-15 | 56 | 163 | 13 | PF00125 |
| Domain | Histone-fold | SUPT3H H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 1.33e-14 | 83 | 163 | 14 | IPR009072 |
| Domain | - | SUPT3H H2AZ2 H2AC21 H2AC14 H2AC6 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 SOS1 SOS2 | 2.66e-14 | 69 | 163 | 13 | 1.10.20.10 |
| Domain | GST_alpha | 2.78e-08 | 5 | 163 | 4 | IPR003080 | |
| Domain | RIH_assoc-dom | 8.27e-08 | 6 | 163 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.27e-08 | 6 | 163 | 4 | PF08709 | |
| Domain | RIH_assoc | 8.27e-08 | 6 | 163 | 4 | PF08454 | |
| Domain | RIH_dom | 8.27e-08 | 6 | 163 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.27e-08 | 6 | 163 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.27e-08 | 6 | 163 | 4 | IPR015925 | |
| Domain | - | 8.27e-08 | 6 | 163 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.27e-08 | 6 | 163 | 4 | PF01365 | |
| Domain | PDEase_N | 6.53e-07 | 3 | 163 | 3 | IPR013706 | |
| Domain | PDEase_I_N | 6.53e-07 | 3 | 163 | 3 | PF08499 | |
| Domain | MIR | 1.13e-06 | 10 | 163 | 4 | PF02815 | |
| Domain | MIR_motif | 1.13e-06 | 10 | 163 | 4 | IPR016093 | |
| Domain | MIR | 1.13e-06 | 10 | 163 | 4 | PS50919 | |
| Domain | MIR | 1.13e-06 | 10 | 163 | 4 | SM00472 | |
| Domain | Ion_trans_dom | 7.12e-06 | 114 | 163 | 8 | IPR005821 | |
| Domain | Ion_trans | 7.12e-06 | 114 | 163 | 8 | PF00520 | |
| Domain | Calx_beta | 3.54e-05 | 8 | 163 | 3 | SM00237 | |
| Domain | GST_N | 3.62e-05 | 22 | 163 | 4 | PF02798 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.62e-05 | 22 | 163 | 4 | IPR000651 | |
| Domain | RASGEF_NTER | 3.62e-05 | 22 | 163 | 4 | PS50212 | |
| Domain | GST_NTER | 3.62e-05 | 22 | 163 | 4 | PS50404 | |
| Domain | ARM-type_fold | DOCK2 ATR NCBP1 CTIF FRYL RALGAPA2 RYR3 ITPR1 NF1 AP2A2 NOC4L UTP20 | 4.41e-05 | 339 | 163 | 12 | IPR016024 |
| Domain | Calx_beta | 5.27e-05 | 9 | 163 | 3 | IPR003644 | |
| Domain | Calx-beta | 5.27e-05 | 9 | 163 | 3 | PF03160 | |
| Domain | RASGEF | 7.20e-05 | 26 | 163 | 4 | PS00720 | |
| Domain | GST_C | 7.20e-05 | 26 | 163 | 4 | IPR004046 | |
| Domain | GST_C | 7.20e-05 | 26 | 163 | 4 | PF00043 | |
| Domain | GST_C_3 | 7.49e-05 | 10 | 163 | 3 | PF14497 | |
| Domain | Glutathione_S-Trfase_N | 8.39e-05 | 27 | 163 | 4 | IPR004045 | |
| Domain | RASGEF_CAT | 1.12e-04 | 29 | 163 | 4 | PS50009 | |
| Domain | RasGEF | 1.28e-04 | 30 | 163 | 4 | PF00617 | |
| Domain | - | 1.28e-04 | 30 | 163 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.28e-04 | 30 | 163 | 4 | IPR001895 | |
| Domain | RasGEF | 1.28e-04 | 30 | 163 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 1.28e-04 | 30 | 163 | 4 | IPR023578 | |
| Domain | CRAL_TRIO_2 | 1.36e-04 | 12 | 163 | 3 | PF13716 | |
| Domain | GST_CTER | 2.11e-04 | 34 | 163 | 4 | PS50405 | |
| Domain | Ryanodine_rcpt | 2.26e-04 | 3 | 163 | 2 | IPR003032 | |
| Domain | InsP3_rcpt-bd | 2.26e-04 | 3 | 163 | 2 | IPR000493 | |
| Domain | Ryanrecept_TM4-6 | 2.26e-04 | 3 | 163 | 2 | IPR009460 | |
| Domain | RyR | 2.26e-04 | 3 | 163 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.26e-04 | 3 | 163 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.26e-04 | 3 | 163 | 2 | IPR013333 | |
| Domain | Glutathione-S-Trfase_C-like | 3.62e-04 | 39 | 163 | 4 | IPR010987 | |
| Domain | - | 3.62e-04 | 39 | 163 | 4 | 1.20.1050.10 | |
| Domain | Tox-GHH_dom | 4.49e-04 | 4 | 163 | 2 | IPR028916 | |
| Domain | CLZ | 4.49e-04 | 4 | 163 | 2 | PF16526 | |
| Domain | Tox-GHH | 4.49e-04 | 4 | 163 | 2 | PF15636 | |
| Domain | Ten_N | 4.49e-04 | 4 | 163 | 2 | IPR009471 | |
| Domain | Ten_N | 4.49e-04 | 4 | 163 | 2 | PF06484 | |
| Domain | CLZ_dom | 4.49e-04 | 4 | 163 | 2 | IPR032406 | |
| Domain | TENEURIN_N | 4.49e-04 | 4 | 163 | 2 | PS51361 | |
| Domain | PDEase | 5.71e-04 | 19 | 163 | 3 | IPR023088 | |
| Domain | Cadherin | 5.94e-04 | 118 | 163 | 6 | IPR002126 | |
| Domain | RasGEFN | 6.67e-04 | 20 | 163 | 3 | SM00229 | |
| Domain | DOCK_N | 7.44e-04 | 5 | 163 | 2 | PF16172 | |
| Domain | DOCK_N | 7.44e-04 | 5 | 163 | 2 | IPR032376 | |
| Domain | YD | 7.44e-04 | 5 | 163 | 2 | IPR006530 | |
| Domain | RasGEF_N | 7.73e-04 | 21 | 163 | 3 | PF00618 | |
| Domain | PDEase_I | 7.73e-04 | 21 | 163 | 3 | PF00233 | |
| Domain | PDEASE_I | 7.73e-04 | 21 | 163 | 3 | PS00126 | |
| Domain | PDEase_CS | 7.73e-04 | 21 | 163 | 3 | IPR023174 | |
| Domain | - | 8.90e-04 | 22 | 163 | 3 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.02e-03 | 23 | 163 | 3 | IPR002073 | |
| Domain | HD/PDEase_dom | 1.15e-03 | 24 | 163 | 3 | IPR003607 | |
| Domain | HDc | 1.15e-03 | 24 | 163 | 3 | SM00471 | |
| Domain | SEC14 | 1.30e-03 | 25 | 163 | 3 | SM00516 | |
| Domain | ENaC | 1.54e-03 | 7 | 163 | 2 | IPR004724 | |
| Domain | CRAL_TRIO | 1.64e-03 | 27 | 163 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 1.82e-03 | 28 | 163 | 3 | IPR001251 | |
| Domain | Na+channel_ASC_CS | 2.05e-03 | 8 | 163 | 2 | IPR020903 | |
| Domain | ASC | 2.62e-03 | 9 | 163 | 2 | PF00858 | |
| Domain | ASC | 2.62e-03 | 9 | 163 | 2 | PS01206 | |
| Domain | Na+channel_ASC | 2.62e-03 | 9 | 163 | 2 | IPR001873 | |
| Domain | MIF4G | 3.25e-03 | 10 | 163 | 2 | SM00543 | |
| Domain | MIF4G | 3.25e-03 | 10 | 163 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 3.25e-03 | 10 | 163 | 2 | IPR003890 | |
| Domain | CA | 3.38e-03 | 115 | 163 | 5 | SM00112 | |
| Domain | Rap_GAP_dom | 3.95e-03 | 11 | 163 | 2 | IPR000331 | |
| Domain | DHR-1_domain | 3.95e-03 | 11 | 163 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.95e-03 | 11 | 163 | 2 | PS51651 | |
| Domain | DHR_1 | 3.95e-03 | 11 | 163 | 2 | PS51650 | |
| Domain | DHR-2 | 3.95e-03 | 11 | 163 | 2 | PF06920 | |
| Domain | DOCK | 3.95e-03 | 11 | 163 | 2 | IPR026791 | |
| Domain | RAPGAP | 3.95e-03 | 11 | 163 | 2 | PS50085 | |
| Domain | DOCK_C | 3.95e-03 | 11 | 163 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.95e-03 | 11 | 163 | 2 | PF14429 | |
| Domain | DHR-2 | 3.95e-03 | 11 | 163 | 2 | IPR027357 | |
| Domain | Cadherin_tail | 4.08e-03 | 37 | 163 | 3 | PF15974 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.65e-11 | 78 | 113 | 11 | M27234 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ C8G H2AC12 | 7.82e-11 | 139 | 113 | 13 | M4741 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 4.22e-10 | 37 | 113 | 8 | M27580 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2AC11 SUPT3H H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AJ H2AC12 PADI3 | 3.54e-08 | 272 | 113 | 14 | M29619 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | 5.84e-08 | 67 | 113 | 8 | M27342 | |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | 1.95e-07 | 78 | 113 | 8 | M1061 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 2.00e-07 | 108 | 113 | 9 | M27426 | |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | 2.61e-07 | 55 | 113 | 7 | M29526 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 3.69e-07 | 116 | 113 | 9 | M29806 | |
| Pathway | REACTOME_MEIOSIS | 4.93e-07 | 120 | 113 | 9 | M529 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 5.01e-07 | 88 | 113 | 8 | M1011 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 5.96e-07 | 90 | 113 | 8 | M2158 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | 5.96e-07 | 90 | 113 | 8 | M27691 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 6.03e-07 | 62 | 113 | 7 | M27700 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.49e-07 | 91 | 113 | 8 | M27101 | |
| Pathway | REACTOME_DNA_METHYLATION | 7.52e-07 | 64 | 113 | 7 | M27429 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 8.34e-07 | 94 | 113 | 8 | M27230 | |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | 9.30e-07 | 66 | 113 | 7 | M27488 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.03e-06 | 67 | 113 | 7 | M39003 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 1.14e-06 | 68 | 113 | 7 | M27658 | |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.39e-06 | 70 | 113 | 7 | M48028 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | 1.39e-06 | 70 | 113 | 7 | M48261 | |
| Pathway | REACTOME_UCH_PROTEINASES | 1.56e-06 | 102 | 113 | 8 | M27576 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.69e-06 | 72 | 113 | 7 | M29714 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.69e-06 | 72 | 113 | 7 | M27132 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.86e-06 | 73 | 113 | 7 | M27166 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.03e-06 | 142 | 113 | 9 | M27233 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 2.12e-06 | 27 | 113 | 5 | MM15908 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 2.23e-06 | 75 | 113 | 7 | M27343 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 2.76e-06 | 110 | 113 | 8 | M27696 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 3.08e-06 | 29 | 113 | 5 | MM15291 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 3.16e-06 | 112 | 113 | 8 | M4052 | |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | 3.16e-06 | 112 | 113 | 8 | M48334 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 3.18e-06 | 79 | 113 | 7 | M27191 | |
| Pathway | PID_RAS_PATHWAY | 3.68e-06 | 30 | 113 | 5 | M269 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 4.36e-06 | 31 | 113 | 5 | MM17225 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 4.38e-06 | 54 | 113 | 6 | M26911 | |
| Pathway | REACTOME_REPRODUCTION | 4.91e-06 | 158 | 113 | 9 | M26956 | |
| Pathway | REACTOME_HCMV_INFECTION | 6.02e-06 | 162 | 113 | 9 | M29804 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 7.07e-06 | 89 | 113 | 7 | M27943 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 7.17e-06 | 125 | 113 | 8 | M27186 | |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | 7.62e-06 | 90 | 113 | 7 | M29668 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 8.60e-06 | 17 | 113 | 4 | MM15891 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 9.47e-06 | 93 | 113 | 7 | M27487 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 9.86e-06 | 6 | 113 | 3 | MM14494 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.08e-05 | 37 | 113 | 5 | MM14883 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.17e-05 | 96 | 113 | 7 | M27792 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.23e-05 | 38 | 113 | 5 | MM15434 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 1.25e-05 | 97 | 113 | 7 | M48262 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.38e-05 | 19 | 113 | 4 | M47809 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.38e-05 | 19 | 113 | 4 | M47760 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.40e-05 | 39 | 113 | 5 | MM14850 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.48e-05 | 138 | 113 | 8 | M29805 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.56e-05 | 67 | 113 | 6 | MM15429 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.56e-05 | 139 | 113 | 8 | M868 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.56e-05 | 139 | 113 | 8 | M715 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.59e-05 | 40 | 113 | 5 | MM14936 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.72e-05 | 20 | 113 | 4 | MM14721 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.80e-05 | 41 | 113 | 5 | M512 | |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | 1.98e-05 | 104 | 113 | 7 | M29829 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 2.10e-05 | 105 | 113 | 7 | M27425 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.24e-05 | 106 | 113 | 7 | M27458 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 2.38e-05 | 107 | 113 | 7 | M48260 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.56e-05 | 22 | 113 | 4 | MM15888 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 2.56e-05 | 22 | 113 | 4 | MM1449 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.56e-05 | 44 | 113 | 5 | MM15527 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 2.76e-05 | 74 | 113 | 6 | MM14605 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 3.02e-05 | 111 | 113 | 7 | M27187 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 3.08e-05 | 23 | 113 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 3.67e-05 | 24 | 113 | 4 | M47487 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.72e-05 | 119 | 113 | 7 | M607 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 4.81e-05 | 50 | 113 | 5 | MM15308 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 4.81e-05 | 50 | 113 | 5 | M1840 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 5.53e-05 | 122 | 113 | 7 | M29689 | |
| Pathway | REACTOME_CGMP_EFFECTS | 5.78e-05 | 10 | 113 | 3 | MM15054 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 5.96e-05 | 27 | 113 | 4 | MM15693 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2AZ2 TERT ITPR1 ITPR3 H2AC14 H2AC6 H2AC4 AP2A2 H2AC7 H2AX H2AJ | 6.79e-05 | 330 | 113 | 11 | M7847 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 7.00e-05 | 54 | 113 | 5 | MM14904 | |
| Pathway | REACTOME_DNA_REPAIR | RAD51C H2AZ2 ATR H2AC14 PARP1 H2AC6 H2AC4 GTF2H4 H2AC7 H2AX H2AJ | 7.16e-05 | 332 | 113 | 11 | M15434 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 7.51e-05 | 128 | 113 | 7 | M48019 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 7.65e-05 | 55 | 113 | 5 | MM14932 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 7.89e-05 | 129 | 113 | 7 | M27795 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 8.35e-05 | 56 | 113 | 5 | MM17236 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 8.36e-05 | 90 | 113 | 6 | M6467 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 9.15e-05 | 178 | 113 | 8 | M2890 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 9.45e-05 | 92 | 113 | 6 | MM15823 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.18e-04 | 32 | 113 | 4 | MM14719 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | DOCK2 H2AC11 SEC24A H2AC21 NCBP1 TSG101 YES1 ITPR1 ITPR3 H2AC14 PARP1 H2AC6 H2AC4 GTF2H4 AP2A2 MAVS H2AC1 H2AC7 HSPA8 H2AC12 SOS1 | 1.21e-04 | 1081 | 113 | 21 | M27548 |
| Pathway | WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA | 1.34e-04 | 33 | 113 | 4 | M39800 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.35e-04 | 13 | 113 | 3 | M39589 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 1.35e-04 | 13 | 113 | 3 | MM15015 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.44e-04 | 142 | 113 | 7 | M48257 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.44e-04 | 142 | 113 | 7 | M27660 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.67e-04 | 102 | 113 | 6 | MM15430 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.84e-04 | 197 | 113 | 8 | M27188 | |
| Pathway | REACTOME_HEMOSTASIS | RAD51C DOCK2 MAG DOCK4 PDE1A PDE1B YES1 ITPR1 ITPR3 RASGRP1 KIF9 GNA15 KIFC1 SOS1 | 1.86e-04 | 571 | 113 | 14 | MM14472 |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.89e-04 | 36 | 113 | 4 | M1443 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.94e-04 | 149 | 113 | 7 | M27888 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.03e-04 | 254 | 113 | 9 | M27131 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.34e-04 | 38 | 113 | 4 | MM14600 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.51e-16 | 69 | 166 | 12 | 11689053 |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.33e-15 | 73 | 166 | 12 | 14657027 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.33e-15 | 73 | 166 | 12 | 9566873 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.59e-15 | 74 | 166 | 12 | 36180920 | |
| Pubmed | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.05e-14 | 86 | 166 | 12 | 11080476 | |
| Pubmed | H2AC11 H2AC21 H2AC14 PARP1 H2AC6 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 1.53e-11 | 88 | 166 | 10 | 26318153 | |
| Pubmed | Precise characterization of human histones in the H2A gene family by top down mass spectrometry. | 3.14e-11 | 14 | 166 | 6 | 16457589 | |
| Pubmed | 9.22e-11 | 30 | 166 | 7 | 16319397 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | H2AC11 H2AZ2 ANPEP H2AC21 SI CP TSG101 LCP1 GSTA1 GSTA2 GSTA3 ARHGAP1 FREM2 H2AC6 H2AC4 H2AC1 GSTA5 H2AC7 H2AX H2AZ1 H2AJ C8G HSPA8 H2AC12 | 3.39e-10 | 1070 | 166 | 24 | 23533145 |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 12557262 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 1728405 | ||
| Pubmed | Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice. | 5.01e-10 | 4 | 166 | 4 | 24964013 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2049074 | ||
| Pubmed | Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes. | 5.01e-10 | 4 | 166 | 4 | 27198676 | |
| Pubmed | Mouse glutathione S-transferase Ya subunit: gene structure and sequence. | 5.01e-10 | 4 | 166 | 4 | 3652905 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 9606968 | ||
| Pubmed | 5'-flanking sequence of mouse glutathione S-transferase Ya gene. | 5.01e-10 | 4 | 166 | 4 | 2893339 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 1526290 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 16786188 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6330685 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 19029078 | ||
| Pubmed | DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. | 1.05e-09 | 11 | 166 | 5 | 16702407 | |
| Pubmed | 1.05e-09 | 11 | 166 | 5 | 15078818 | ||
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 1.80e-09 | 12 | 166 | 5 | 8297798 | |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 9268051 | ||
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 12020353 | ||
| Pubmed | Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. | 2.49e-09 | 5 | 166 | 4 | 3417659 | |
| Pubmed | Expression pattern of GSTP1 and GSTA1 in the pathogenesis of asthma. | 2.49e-09 | 5 | 166 | 4 | 23647087 | |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 11851347 | ||
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 16243960 | ||
| Pubmed | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. | 2.91e-09 | 13 | 166 | 5 | 15823041 | |
| Pubmed | 3.62e-09 | 77 | 166 | 8 | 12408966 | ||
| Pubmed | H2AZ2 PCDHGA9 PCDHGA7 SPEF2 PCLO UGGT1 DNAJC21 H2AC21 NCBP1 LCP1 RYR2 H2AC14 PARP1 H2AC6 H2AC4 AP2A2 PCDHGA12 H2AC1 TENM1 H2AC7 H2AX H2AZ1 IFT122 H2AJ HSPA8 H2AC12 | 5.71e-09 | 1442 | 166 | 26 | 35575683 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 7.45e-09 | 6 | 166 | 4 | 25966694 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 20519450 | ||
| Pubmed | Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. | 7.45e-09 | 6 | 166 | 4 | 14672804 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 7.45e-09 | 6 | 166 | 4 | 16844763 | |
| Pubmed | 9.76e-09 | 16 | 166 | 5 | 15386022 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 1427837 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 8584275 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 11860456 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 7894162 | ||
| Pubmed | Phosphorylation of histone H2A inhibits transcription on chromatin templates. | 1.90e-08 | 18 | 166 | 5 | 15010469 | |
| Pubmed | Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. | 2.57e-08 | 19 | 166 | 5 | 16359901 | |
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 16284450 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 7774561 | ||
| Pubmed | Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. | 6.19e-08 | 9 | 166 | 4 | 1685137 | |
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 15870285 | ||
| Pubmed | Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers. | 1.03e-07 | 10 | 166 | 4 | 25731851 | |
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 1981995 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 9003415 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 18335582 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 7568196 | ||
| Pubmed | Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes. | 1.07e-07 | 3 | 166 | 3 | 17726023 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 22586275 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAD51C H2AC11 EMC1 H2AZ2 UGGT1 TTC27 NCBP1 GTF3C4 H2AC14 PARP1 H2AC6 H2AC4 NOP58 ERGIC3 AGL H2AC7 H2AX H2AZ1 H2AJ OGA HSPA8 H2AC12 | 1.60e-07 | 1257 | 166 | 22 | 37317656 |
| Pubmed | Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. | 1.61e-07 | 11 | 166 | 4 | 21554947 | |
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 15100242 | ||
| Pubmed | H2AC11 H2AZ2 H2AC21 NCBP1 LCP1 YES1 H2AC14 PARP1 H2AC6 H2AC4 NOP58 AP2A2 H2AC1 AGL H2AC7 H2AX H2AZ1 NOC4L H2AJ HSPA8 H2AC12 | 1.63e-07 | 1153 | 166 | 21 | 29845934 | |
| Pubmed | 3.46e-07 | 13 | 166 | 4 | 9441664 | ||
| Pubmed | 3.46e-07 | 13 | 166 | 4 | 36421460 | ||
| Pubmed | 3.46e-07 | 13 | 166 | 4 | 2572508 | ||
| Pubmed | 4.23e-07 | 32 | 166 | 5 | 30532072 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 8307579 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.26e-07 | 4 | 166 | 3 | 23413940 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 9607712 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 24109434 | ||
| Pubmed | Quantitative determination of histone modification. H2A acetylation and phosphorylation. | 4.26e-07 | 4 | 166 | 3 | 7217105 | |
| Pubmed | 8.47e-07 | 67 | 166 | 6 | 25253489 | ||
| Pubmed | 8.71e-07 | 16 | 166 | 4 | 8649810 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 8081710 | ||
| Pubmed | Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant. | 1.06e-06 | 5 | 166 | 3 | 11331621 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 23650189 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 23209318 | ||
| Pubmed | H2AZ2 ABCA12 H2AC21 H2AC14 PARP1 H2AC6 H2AC1 TENM1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.25e-06 | 513 | 166 | 13 | 25798074 | |
| Pubmed | 1.45e-06 | 18 | 166 | 4 | 29743367 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.50e-06 | 116 | 166 | 7 | 22810585 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.85e-06 | 231 | 166 | 9 | 36597993 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 19812697 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 35849344 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 14764585 | ||
| Pubmed | 3.38e-06 | 48 | 166 | 5 | 8884266 | ||
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 30720883 | ||
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 26836306 | ||
| Pubmed | 4.94e-06 | 24 | 166 | 4 | 33220177 | ||
| Pubmed | Evidence for the involvement of ASIC3 in sensory mechanotransduction in proprioceptors. | 5.88e-06 | 8 | 166 | 3 | 27161260 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.88e-06 | 8 | 166 | 3 | 19033399 | |
| Pubmed | 5.88e-06 | 8 | 166 | 3 | 29985131 | ||
| Pubmed | 6.69e-06 | 55 | 166 | 5 | 9439656 | ||
| Pubmed | Resveratrol improves health and survival of mice on a high-calorie diet. | 6.89e-06 | 26 | 166 | 4 | 17086191 | |
| Pubmed | The genomic organization of the histone clusters on human 6p21.3. | 8.78e-06 | 9 | 166 | 3 | 10384058 | |
| Pubmed | 1.13e-05 | 289 | 166 | 9 | 37132043 | ||
| Pubmed | 1.25e-05 | 30 | 166 | 4 | 20200426 | ||
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 26751069 | ||
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 38713721 | ||
| Pubmed | NPC1 GAD2 DCHS2 CFAP91 TTC27 NCBP1 ACOT1 TSG101 SMG5 GTF3C4 RYR3 ARHGAP1 UBE4A PARP1 NAA25 MAST1 IFT122 SOS1 SOS2 | 1.33e-05 | 1285 | 166 | 19 | 35914814 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H2AC11 H2AZ2 DNAJC21 ITPR1 ITPR3 H2AC14 PARP1 NOP58 AP2A2 H2AC7 H2AZ1 UTP20 H2AJ HSPA8 H2AC12 KIFC1 | 1.38e-05 | 949 | 166 | 16 | 36574265 |
| Pubmed | DOCK2 H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 AP2A2 H2AC1 H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 1.41e-05 | 844 | 166 | 15 | 25963833 | |
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 25362550 | ||
| Interaction | H2BC5 interactions | SHLD2 H2AC11 H2AZ2 PCDHGA9 PCDHGA7 VPS13C PCLO H2AC21 SMG5 H2AC14 PARP1 H2AC6 H2AC4 PCDHGA12 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.94e-12 | 331 | 163 | 20 | int:H2BC5 |
| Interaction | H2BC17 interactions | H2AC11 PCLO H2AC21 H2AC14 PARP1 H2AC6 H2AC4 KBTBD4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 7.88e-12 | 140 | 163 | 14 | int:H2BC17 |
| Interaction | LOC102724334 interactions | H2AC11 H2AZ2 PCLO H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.65e-11 | 134 | 163 | 13 | int:LOC102724334 |
| Interaction | H3C15 interactions | H2AC11 H2AC21 GTF3C4 FSIP2 H2AC14 PARP1 H2AC6 H2AC4 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 1.42e-10 | 207 | 163 | 15 | int:H3C15 |
| Interaction | H2BC11 interactions | H2AC11 H2AZ2 PCLO H2AC21 H2AC14 H2AC6 H2AC4 KBTBD4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.62e-10 | 186 | 163 | 14 | int:H2BC11 |
| Interaction | H2BC18 interactions | H2AC11 H2AZ2 PCLO H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 2.62e-09 | 180 | 163 | 13 | int:H2BC18 |
| Interaction | H2BC26 interactions | H2AC11 PCLO H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.20e-09 | 183 | 163 | 13 | int:H2BC26 |
| Interaction | H2AC1 interactions | 5.75e-09 | 71 | 163 | 9 | int:H2AC1 | |
| Interaction | H2AC6 interactions | H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC1 H2AC7 H2AZ1 H2AJ H2AC12 | 8.41e-09 | 100 | 163 | 10 | int:H2AC6 |
| Interaction | H2AC7 interactions | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AJ H2AC12 | 1.63e-08 | 107 | 163 | 10 | int:H2AC7 |
| Interaction | H2BC15 interactions | H2AC11 PCLO H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AJ H2AC12 | 2.56e-08 | 144 | 163 | 11 | int:H2BC15 |
| Interaction | H3-5 interactions | H2AZ2 H2AC14 PARP1 H2AC6 H2AC4 SUV39H1 H2AC7 H2AX H2AJ H2AC12 | 3.00e-08 | 114 | 163 | 10 | int:H3-5 |
| Interaction | H2AC13 interactions | 1.64e-07 | 75 | 163 | 8 | int:H2AC13 | |
| Interaction | H2AC14 interactions | DNAJC21 H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC1 H2AC7 H2AJ H2AC12 | 2.75e-07 | 144 | 163 | 10 | int:H2AC14 |
| Interaction | H2BC12 interactions | H2AC11 H2AZ2 VPS26B PCLO H2AC14 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 3.79e-07 | 322 | 163 | 14 | int:H2BC12 |
| Interaction | H2AC21 interactions | H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 4.69e-07 | 234 | 163 | 12 | int:H2AC21 |
| Interaction | H2AC12 interactions | 5.00e-07 | 118 | 163 | 9 | int:H2AC12 | |
| Interaction | H3-4 interactions | H2AC11 SUPT3H H2AZ2 H2AC21 GTF3C4 H2AC14 PARP1 H2AC6 H2AC4 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 7.60e-07 | 448 | 163 | 16 | int:H3-4 |
| Interaction | GSTA2 interactions | 8.34e-07 | 10 | 163 | 4 | int:GSTA2 | |
| Interaction | H2AJ interactions | 9.31e-07 | 127 | 163 | 9 | int:H2AJ | |
| Interaction | H2BC3 interactions | H2AC11 H2AC21 GTF3C4 H2AC14 PARP1 H2AC6 H2AC4 NOP58 KBTBD4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.13e-06 | 406 | 163 | 15 | int:H2BC3 |
| Interaction | H2BC1 interactions | H2AC11 H2AZ2 VPS13C H2AC21 PARP1 H2AC6 H2AC4 H2AC1 H2AX H2AZ1 | 1.93e-06 | 178 | 163 | 10 | int:H2BC1 |
| Interaction | H2AC18 interactions | 3.33e-06 | 148 | 163 | 9 | int:H2AC18 | |
| Interaction | GSTA3 interactions | 5.13e-06 | 5 | 163 | 3 | int:GSTA3 | |
| Interaction | H2AC25 interactions | 5.35e-06 | 84 | 163 | 7 | int:H2AC25 | |
| Interaction | H2BC13 interactions | 8.40e-06 | 210 | 163 | 10 | int:H2BC13 | |
| Interaction | MCM5 interactions | H2AC11 H2AZ2 H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 8.47e-06 | 420 | 163 | 14 | int:MCM5 |
| Interaction | H2BC4 interactions | H2AC11 H2AZ2 VPS26B FSIP2 PARP1 H2AC6 H2AC4 H2AC7 H2AX H2AZ1 H2AC12 | 8.76e-06 | 259 | 163 | 11 | int:H2BC4 |
| Interaction | HMGN2 interactions | H2AC11 H2AZ2 PCLO TSG101 H2AC14 PARP1 H2AC6 H2AC4 HSPA8 H2AC12 | 1.36e-05 | 222 | 163 | 10 | int:HMGN2 |
| Interaction | H2AC4 interactions | H2AC11 H2AC21 GTF3C4 H2AC14 PARP1 H2AC6 H2AC4 NOP58 H2AC1 H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 1.61e-05 | 506 | 163 | 15 | int:H2AC4 |
| Interaction | H2BC9 interactions | H2AC11 H2AZ2 PCLO DNAJC21 H2AC21 FSIP2 H2AC14 PARP1 H2AC4 H2AC7 H2AX H2AZ1 FGD6 H2AC12 | 1.66e-05 | 446 | 163 | 14 | int:H2BC9 |
| Interaction | GSTA1 interactions | 2.69e-05 | 22 | 163 | 4 | int:GSTA1 | |
| Interaction | MIER3 interactions | 3.24e-05 | 23 | 163 | 4 | int:MIER3 | |
| Interaction | ARRB1 interactions | DOCK4 H2AC11 ATR MC1R H2AC21 YES1 MAP3K5 SLC9A5 H2AX CNGA3 HSPA8 | 3.86e-05 | 304 | 163 | 11 | int:ARRB1 |
| Interaction | GSTA5 interactions | 4.21e-05 | 9 | 163 | 3 | int:GSTA5 | |
| Interaction | H2BC21 interactions | H2AC11 PCLO DNAJC21 H2AC21 SMG5 H2AC14 PARP1 H2AC6 H2AC4 KBTBD4 H2AC1 TENM1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 5.10e-05 | 696 | 163 | 17 | int:H2BC21 |
| Interaction | PCDHGA12 interactions | 5.98e-05 | 10 | 163 | 3 | int:PCDHGA12 | |
| Interaction | H2AC20 interactions | H2AC11 H2AC14 H2AC6 H2AC4 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 6.13e-05 | 320 | 163 | 11 | int:H2AC20 |
| Interaction | CD2AP interactions | 6.32e-05 | 214 | 163 | 9 | int:CD2AP | |
| Interaction | DUOX2 interactions | 9.59e-05 | 30 | 163 | 4 | int:DUOX2 | |
| Interaction | GSTA4 interactions | 1.08e-04 | 12 | 163 | 3 | int:GSTA4 | |
| Interaction | H3-7 interactions | 1.27e-04 | 137 | 163 | 7 | int:H3-7 | |
| Interaction | EPS15L1 interactions | 1.33e-04 | 138 | 163 | 7 | int:EPS15L1 | |
| Interaction | PDE1C interactions | 1.40e-04 | 13 | 163 | 3 | int:PDE1C | |
| Interaction | EFNA4 interactions | 1.47e-04 | 239 | 163 | 9 | int:EFNA4 | |
| Interaction | HEXIM1 interactions | H2AC11 H2AZ2 H2AC21 NCBP1 LCP1 YES1 H2AC14 PARP1 H2AC6 H2AC4 AP2A2 H2AC1 AGL H2AC7 H2AX H2AZ1 H2AJ HSPA8 H2AC12 | 1.52e-04 | 913 | 163 | 19 | int:HEXIM1 |
| Interaction | H2BC14 interactions | 1.63e-04 | 100 | 163 | 6 | int:H2BC14 | |
| Interaction | HMGN4 interactions | 1.63e-04 | 100 | 163 | 6 | int:HMGN4 | |
| Interaction | METTL14 interactions | UGGT1 NCBP1 RYR3 PARP1 H2AC6 H2AC4 NOP58 AP2A2 H2AC1 H2AX H2AZ1 COL14A1 HSPA8 H2AC12 | 1.83e-04 | 558 | 163 | 14 | int:METTL14 |
| Interaction | CRAMP1 interactions | 2.21e-04 | 37 | 163 | 4 | int:CRAMP1 | |
| Interaction | H3C2 interactions | 2.25e-04 | 68 | 163 | 5 | int:H3C2 | |
| Interaction | AKAP1 interactions | CFAP91 EMC1 VPS13C UGGT1 FBXL4 ITPR3 ARHGAP1 ARL3 NAA25 KBTBD4 MAVS UTP20 HSPA8 | 2.35e-04 | 503 | 163 | 13 | int:AKAP1 |
| Interaction | PRKCB interactions | 2.38e-04 | 255 | 163 | 9 | int:PRKCB | |
| Interaction | H1-0 interactions | 2.45e-04 | 256 | 163 | 9 | int:H1-0 | |
| Interaction | H1-1 interactions | H2AC11 PCLO H2AC21 H2AC14 PARP1 H2AC6 H2AC4 H2AC7 H2AX H2AZ1 NOC4L PRLR H2AC12 | 2.53e-04 | 507 | 163 | 13 | int:H1-1 |
| Interaction | CIT interactions | H2AC11 PCLO H2AC21 NCBP1 CTIF ADGRV1 RALGAPA2 GTF3C4 MAP3K5 ITPR3 H2AC6 H2AC4 NOP58 AP2A2 SLC12A9 P4HA1 H2AC1 SUV39H1 H2AC7 H2AX H2AZ1 NOC4L UTP20 H2AJ HSPA8 | 2.61e-04 | 1450 | 163 | 25 | int:CIT |
| Interaction | ABL1 interactions | 2.67e-04 | 259 | 163 | 9 | int:ABL1 | |
| Interaction | HCLS1 interactions | 2.76e-04 | 71 | 163 | 5 | int:HCLS1 | |
| Interaction | VSIG1 interactions | 2.94e-04 | 72 | 163 | 5 | int:VSIG1 | |
| Interaction | DPPA2 interactions | 3.00e-04 | 40 | 163 | 4 | int:DPPA2 | |
| Interaction | PPM1G interactions | 3.24e-04 | 325 | 163 | 10 | int:PPM1G | |
| Interaction | ANP32E interactions | 3.47e-04 | 115 | 163 | 6 | int:ANP32E | |
| Interaction | H2BC20P interactions | 3.63e-04 | 42 | 163 | 4 | int:H2BC20P | |
| Interaction | C9orf72 interactions | RAD51C H2AC11 EMC1 H2AZ2 UGGT1 TTC27 NCBP1 GTF3C4 H2AC14 PARP1 H2AC6 H2AC4 NOP58 ERGIC3 MAVS AGL H2AC7 H2AX H2AZ1 H2AJ OGA HSPA8 H2AC12 | 4.02e-04 | 1319 | 163 | 23 | int:C9orf72 |
| Interaction | PCDHGB1 interactions | 4.02e-04 | 77 | 163 | 5 | int:PCDHGB1 | |
| Cytoband | 5p13.2 | 1.94e-04 | 31 | 166 | 3 | 5p13.2 | |
| Cytoband | 6p12.1 | 2.34e-04 | 33 | 166 | 3 | 6p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 4.80e-04 | 378 | 166 | 7 | chr6p22 | |
| GeneFamily | Histones | H2AC11 H2AZ2 H2AC21 H2AC14 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AJ H2AC12 | 1.07e-11 | 116 | 116 | 12 | 864 |
| GeneFamily | Glutathione S-transferases | 1.83e-05 | 25 | 116 | 4 | 567 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.22e-04 | 3 | 116 | 2 | 297 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.22e-04 | 3 | 116 | 2 | 287 | |
| GeneFamily | Acid sensing ion channel subunits | 4.03e-04 | 5 | 116 | 2 | 290 | |
| GeneFamily | Phosphodiesterases | 4.72e-04 | 24 | 116 | 3 | 681 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 8.39e-04 | 7 | 116 | 2 | 1299 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.78e-03 | 10 | 116 | 2 | 250 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.06e-03 | 15 | 116 | 2 | 26 | |
| Coexpression | WENG_POR_DOSAGE | 1.17e-06 | 30 | 165 | 5 | MM1199 | |
| Coexpression | FISCHER_DREAM_TARGETS | RAD51C H2AC11 DCAF15 H2AZ2 H2AC21 NCBP1 SKA2 DEPDC1 H2AC14 H2AC6 H2AC4 NOP58 SUV39H1 H2AC7 H2AX H2AZ1 TSEN15 HSPA8 H2AC12 KIFC1 | 3.27e-06 | 969 | 165 | 20 | M149 |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN | 1.46e-05 | 24 | 165 | 4 | MM708 | |
| Coexpression | WENG_POR_TARGETS_GLOBAL_UP | 1.46e-05 | 24 | 165 | 4 | MM1190 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | H2AC11 GAD2 SUPT3H VPS26B ATCAY PCLO CTIF FRYL ADGRV1 LCP1 TENM2 UBE4A H2AC6 H2AC4 H2AC7 H2AX MAST1 OGA TSEN15 H2AC12 SOS1 | 1.39e-05 | 979 | 159 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 3.05e-05 | 80 | 159 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | H2AC11 H2AZ2 H2AC21 DEPDC1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AC12 KIFC1 | 8.33e-12 | 191 | 166 | 12 | a3c5a913a99f17633c140ec9ece81b73e59e0715 |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AZ2 H2AC21 DEPDC1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AC12 | 1.36e-10 | 188 | 166 | 11 | be3db9768364568f44e32ae6b3bf99e49b0978bb |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 DEPDC1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AC12 KIFC1 | 1.36e-10 | 188 | 166 | 11 | b240ea20750ffb825cb5fe41d06c632233406ab6 |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | H2AC11 H2AC21 DEPDC1 H2AC6 H2AC4 H2AC1 H2AC7 H2AX H2AZ1 H2AC12 KIFC1 | 1.61e-10 | 191 | 166 | 11 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | H2AZ2 DEPDC1 TERT H2AC14 PARP1 H2AC4 H2AZ1 FGD6 H2AC12 KIFC1 | 3.78e-09 | 197 | 166 | 10 | 80a0cfbd454409594effead7082586b06c2f411a |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 9.27e-09 | 111 | 166 | 8 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.78e-08 | 181 | 166 | 9 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-08 | 193 | 166 | 9 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-08 | 194 | 166 | 9 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-08 | 195 | 166 | 9 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.28e-08 | 199 | 166 | 9 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.56e-08 | 200 | 166 | 9 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | critical-Lymphoid-NKT-proliferating|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.56e-08 | 200 | 166 | 9 | d698458b90bf8256fe664618ef27620aa910b02a | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.79e-07 | 172 | 166 | 8 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.95e-07 | 180 | 166 | 8 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-07 | 184 | 166 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-07 | 184 | 166 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-07 | 184 | 166 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.28e-07 | 187 | 166 | 8 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.72e-07 | 189 | 166 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 5.72e-07 | 189 | 166 | 8 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.19e-07 | 191 | 166 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-07 | 191 | 166 | 8 | ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.19e-07 | 191 | 166 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 6.44e-07 | 192 | 166 | 8 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 6.44e-07 | 192 | 166 | 8 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.53e-07 | 196 | 166 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-07 | 196 | 166 | 8 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.82e-07 | 197 | 166 | 8 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.82e-07 | 197 | 166 | 8 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.82e-07 | 197 | 166 | 8 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.82e-07 | 197 | 166 | 8 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 7.82e-07 | 197 | 166 | 8 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.82e-07 | 197 | 166 | 8 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.82e-07 | 197 | 166 | 8 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.82e-07 | 197 | 166 | 8 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 198 | 166 | 8 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.12e-07 | 198 | 166 | 8 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 198 | 166 | 8 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-06 | 142 | 166 | 7 | 7bd05d0c0ac2dee0e6cc0f3c531f9154bf300c75 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-06 | 142 | 166 | 7 | 328d08ba2712cd42bb9846ac4d7453ae165b75e2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-06 | 142 | 166 | 7 | 94774d3e598d074f48146b0b094705dc48af5a1f | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.07e-06 | 142 | 166 | 7 | 92bf826827b3e3387ad326566556fc90c5c2f4d5 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.77e-06 | 153 | 166 | 7 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.77e-06 | 153 | 166 | 7 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.77e-06 | 153 | 166 | 7 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.77e-06 | 153 | 166 | 7 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 154 | 166 | 7 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 158 | 166 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 158 | 166 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-06 | 164 | 166 | 7 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | Ionocyte-iono-3|World / Class top | 3.04e-06 | 166 | 166 | 7 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.42e-06 | 169 | 166 | 7 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.47e-06 | 176 | 166 | 7 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.47e-06 | 176 | 166 | 7 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-06 | 177 | 166 | 7 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-06 | 180 | 166 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-06 | 180 | 166 | 7 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-06 | 180 | 166 | 7 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 181 | 166 | 7 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 181 | 166 | 7 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.99e-06 | 184 | 166 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-06 | 184 | 166 | 7 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 185 | 166 | 7 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 186 | 166 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 186 | 166 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 6.89e-06 | 188 | 166 | 7 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 188 | 166 | 7 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.89e-06 | 188 | 166 | 7 | 15146fd2c5592ea84d20b1fdd172b39cd60b5bed | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.64e-06 | 191 | 166 | 7 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.64e-06 | 191 | 166 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.64e-06 | 191 | 166 | 7 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.64e-06 | 191 | 166 | 7 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 7.64e-06 | 191 | 166 | 7 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.64e-06 | 191 | 166 | 7 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 192 | 166 | 7 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality-16|World / Primary Cells by Cluster | 7.90e-06 | 192 | 166 | 7 | 0d6413df15dfecdffc777fb02df3aaf0c30540b1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-06 | 192 | 166 | 7 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 192 | 166 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality|World / Primary Cells by Cluster | 7.90e-06 | 192 | 166 | 7 | 5fa5b2f250ec5ad5a232c022266f0cd01ff4a753 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 8.18e-06 | 193 | 166 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 194 | 166 | 7 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.46e-06 | 194 | 166 | 7 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.46e-06 | 194 | 166 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-06 | 128 | 166 | 6 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.74e-06 | 195 | 166 | 7 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 8.74e-06 | 195 | 166 | 7 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.74e-06 | 195 | 166 | 7 | 3c5b7cce4a1c4b28fa3b657cce4148669a59e55e | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 195 | 166 | 7 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-06 | 195 | 166 | 7 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-06 | 196 | 166 | 7 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| Drug | quercetin 3-arabinopyranoside | 3.85e-08 | 6 | 164 | 4 | ctd:C428865 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 8.93e-08 | 7 | 164 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 8.93e-08 | 7 | 164 | 4 | CID003081001 | |
| Drug | chloride | H2AZ2 ASIC2 H2AC21 PKD2L1 CP GRID2 APOL1 GSTA1 GSTA2 GSTA3 ITPR1 ITPR3 H2AC4 KIF9 SLC9A5 AP2A2 SLC12A9 H2AC1 GSTA5 SLC6A5 H2AX H2AZ1 H2AJ C8G | 3.78e-07 | 1029 | 164 | 24 | CID000000312 |
| Drug | valproate | GAD2 H2AZ2 MC1R H2AC21 ADGRV1 RYR2 RYR3 ITPR1 ITPR3 PCDHGA12 H2AC1 H2AX H2AZ1 H2AJ | 7.26e-07 | 381 | 164 | 14 | CID000003121 |
| Drug | R 478 | 8.23e-07 | 11 | 164 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 8.23e-07 | 11 | 164 | 4 | CID003081323 | |
| Drug | N-myristoyl-rkrtlrrl | 9.40e-07 | 46 | 164 | 6 | CID003081274 | |
| Drug | zinc chloride (ZnCl2 | 1.03e-06 | 186 | 164 | 10 | CID000005727 | |
| Drug | benzotriazole | 1.46e-06 | 4 | 164 | 3 | ctd:C012771 | |
| Drug | MgCl2 | MAG H2AZ2 MC1R H2AC21 RHBDL2 PLPP2 H2AC1 H2AX H2AZ1 H2AJ OGA DNASE1L2 PRLR | 1.85e-06 | 354 | 164 | 13 | CID000024584 |
| Drug | W7 hydrochloride | PDE1C H2AZ2 PDE1B H2AC21 RYR3 ITPR1 ITPR3 H2AC1 H2AX H2AZ1 H2AJ | 2.10e-06 | 250 | 164 | 11 | CID000005681 |
| Drug | CAS 1400-61-9 | 2.21e-06 | 53 | 164 | 6 | CID000004568 | |
| Drug | Dcvg | 2.66e-06 | 31 | 164 | 5 | CID006437359 | |
| Drug | 5-methyl-dCTP | 2.76e-06 | 55 | 164 | 6 | CID000161376 | |
| Drug | Gvapspat amide | 3.33e-06 | 15 | 164 | 4 | CID000125015 | |
| Drug | Benzoxazoles | 3.63e-06 | 5 | 164 | 3 | ctd:D001583 | |
| Drug | Selenium Compounds | 3.63e-06 | 5 | 164 | 3 | ctd:D018036 | |
| Drug | SK-7041 | 4.63e-06 | 60 | 164 | 6 | CID006918714 | |
| Drug | chlorambucil | 5.58e-06 | 133 | 164 | 8 | CID000002708 | |
| Drug | 17alpha-estradiol | RAD51C H2AZ2 ANPEP MC1R MMP27 H2AC21 TSG101 APOL1 YES1 TERT GSTA2 ITPR1 ITPR3 H2AC6 ARL3 NAA25 PLPP2 P4HA1 H2AC1 H2AX H2AZ1 CCR4 H2AJ HSPA8 PRLR | 7.09e-06 | 1303 | 164 | 25 | CID000000450 |
| Drug | NSC7524 | 7.15e-06 | 182 | 164 | 9 | CID000005657 | |
| Drug | 2-allylphenol | 7.22e-06 | 6 | 164 | 3 | ctd:C099328 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 7.22e-06 | 6 | 164 | 3 | ctd:C028328 | |
| Drug | 1-cyano-2-hydroxy-3-butene | 7.22e-06 | 6 | 164 | 3 | ctd:C055903 | |
| Drug | isomethyleugenol | 7.22e-06 | 6 | 164 | 3 | ctd:C031050 | |
| Drug | Isothiocyanates | 7.34e-06 | 18 | 164 | 4 | ctd:D017879 | |
| Drug | Clch2cosg | 7.34e-06 | 18 | 164 | 4 | CID000163913 | |
| Drug | C14791 | 7.34e-06 | 18 | 164 | 4 | CID011954044 | |
| Drug | C14793 | 7.34e-06 | 18 | 164 | 4 | CID011954046 | |
| Drug | C14803 | 7.34e-06 | 18 | 164 | 4 | CID011954054 | |
| Drug | C14805 | 7.34e-06 | 18 | 164 | 4 | CID011954056 | |
| Drug | C14804 | 7.34e-06 | 18 | 164 | 4 | CID011954055 | |
| Drug | C14806 | 7.34e-06 | 18 | 164 | 4 | CID011954057 | |
| Drug | C14848 | 7.34e-06 | 18 | 164 | 4 | CID011954067 | |
| Drug | C14856 | 7.34e-06 | 18 | 164 | 4 | CID011954069 | |
| Drug | C14855 | 7.34e-06 | 18 | 164 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 7.34e-06 | 18 | 164 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 7.34e-06 | 18 | 164 | 4 | CID000188517 | |
| Drug | AC1L98DX | 7.55e-06 | 38 | 164 | 5 | CID000439957 | |
| Drug | isradipine | 8.08e-06 | 100 | 164 | 7 | CID000003784 | |
| Drug | zinc sulfate | 1.05e-05 | 69 | 164 | 6 | CID000024424 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 1.15e-05 | 20 | 164 | 4 | CID011954072 | |
| Drug | C14865 | 1.15e-05 | 20 | 164 | 4 | CID011954073 | |
| Drug | gamma-butyrolactone | 1.34e-05 | 108 | 164 | 7 | CID000007302 | |
| Drug | cafestol | 1.41e-05 | 21 | 164 | 4 | ctd:C053400 | |
| Drug | gadolinium | 1.46e-05 | 199 | 164 | 9 | CID000023982 | |
| Drug | myristate | GAD2 H2AZ2 H2AC21 SLC24A3 YES1 RASGRP1 H2AC1 H2AX H2AZ1 H2AJ HSPA8 | 1.62e-05 | 310 | 164 | 11 | CID000011005 |
| Drug | Berberine | 1.65e-05 | 202 | 164 | 9 | ctd:D001599 | |
| Drug | AC1L9DEH | MAG H2AZ2 ANPEP H2AC21 ADGRL1 GSTA1 GSTA2 GSTA3 PARP1 H2AC1 GSTA5 H2AX H2AZ1 H2AJ HSPA8 | 1.66e-05 | 569 | 164 | 15 | CID000442783 |
| Drug | mustard oil | 1.91e-05 | 114 | 164 | 7 | CID000005971 | |
| Drug | Selenocysteine | 2.00e-05 | 8 | 164 | 3 | ctd:D017279 | |
| Drug | kahweol palmitate | 2.00e-05 | 8 | 164 | 3 | ctd:C033997 | |
| Drug | Glucosinolates | 2.00e-05 | 8 | 164 | 3 | ctd:D005961 | |
| Drug | triethyllead | 2.00e-05 | 8 | 164 | 3 | ctd:C010360 | |
| Drug | 9 mM of H | 2.00e-05 | 8 | 164 | 3 | CID000130464 | |
| Drug | AA-GSH | 2.07e-05 | 23 | 164 | 4 | CID000083998 | |
| Drug | S-(formylmethyl)glutathione | 2.46e-05 | 24 | 164 | 4 | CID011954074 | |
| Drug | gibberellin (GA | 2.81e-05 | 166 | 164 | 8 | CID000006466 | |
| Drug | C04378 | 2.84e-05 | 82 | 164 | 6 | CID000440315 | |
| Drug | T0702 | 2.92e-05 | 25 | 164 | 4 | CID000005908 | |
| Drug | NaBu | 2.96e-05 | 122 | 164 | 7 | CID000052923 | |
| Drug | Chlorambucil | 2.97e-05 | 50 | 164 | 5 | ctd:D002699 | |
| Drug | phenanthroline | 2.97e-05 | 50 | 164 | 5 | CID000067473 | |
| Drug | butane | 3.12e-05 | 123 | 164 | 7 | CID000007843 | |
| Drug | gabapentin | 3.19e-05 | 169 | 164 | 8 | CID000003446 | |
| Drug | fluoride | H2AZ2 H2AC21 ARHGAP1 H2AC1 AGL H2AX H2AZ1 COL14A1 GNA15 H2AJ | 3.53e-05 | 278 | 164 | 10 | CID000014917 |
| Drug | AC1L1FWN | 4.13e-05 | 227 | 164 | 9 | CID000003425 | |
| Drug | imidazole | 4.24e-05 | 10 | 164 | 3 | ctd:C029899 | |
| Drug | aflatoxin B1-2,3-oxide | 4.24e-05 | 10 | 164 | 3 | ctd:C006426 | |
| Drug | PCB 95 | 4.24e-05 | 10 | 164 | 3 | CID000038012 | |
| Drug | Triazoles | 4.24e-05 | 10 | 164 | 3 | ctd:D014230 | |
| Drug | angelica lactone | 4.24e-05 | 10 | 164 | 3 | ctd:C019257 | |
| Drug | AC1Q608X | 4.64e-05 | 28 | 164 | 4 | CID000128466 | |
| Drug | AC1L33DC | 4.64e-05 | 28 | 164 | 4 | CID000133757 | |
| Drug | DADS | 4.67e-05 | 131 | 164 | 7 | CID000016590 | |
| Drug | S-hexylglutathione | 4.74e-05 | 55 | 164 | 5 | CID000005140 | |
| Drug | 5-androstene-3,17-dione | 5.16e-05 | 2 | 164 | 2 | ctd:C003528 | |
| Drug | Isocaffeine | 5.16e-05 | 2 | 164 | 2 | CID000001326 | |
| Drug | adenophostin B | 5.16e-05 | 2 | 164 | 2 | CID000656722 | |
| Drug | iproplatin | 5.16e-05 | 2 | 164 | 2 | ctd:C023359 | |
| Drug | benzene 1,2,4-trisphosphate | 5.16e-05 | 2 | 164 | 2 | CID000192376 | |
| Drug | strychnine HCl | 5.20e-05 | 181 | 164 | 8 | CID000005304 | |
| Drug | 2-BHA | 5.36e-05 | 29 | 164 | 4 | CID000006932 | |
| Drug | cyclohexanone | 5.64e-05 | 57 | 164 | 5 | CID000007967 | |
| Drug | 8-bromoguanosine | 5.79e-05 | 93 | 164 | 6 | CID000092977 | |
| Drug | 4-propylphenol | 5.80e-05 | 11 | 164 | 3 | ctd:C099327 | |
| Drug | o-dinitrobenzene | 7.02e-05 | 31 | 164 | 4 | CID000010707 | |
| Drug | procainamide | 7.31e-05 | 190 | 164 | 8 | CID000004913 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 7.58e-05 | 191 | 164 | 8 | 6721_DN | |
| Drug | propranolol | H2AZ2 H2AC21 APOL1 RYR2 RYR3 ITPR1 ITPR3 PLPP2 H2AC1 H2AX H2AZ1 H2AJ | 7.62e-05 | 434 | 164 | 12 | CID000004946 |
| Drug | indo-1 | 8.22e-05 | 99 | 164 | 6 | CID000105060 | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; HL60; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 2163_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 5305_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 2426_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 2852_DN | |
| Drug | CNS 1145 | 9.02e-05 | 33 | 164 | 4 | CID000190902 | |
| Drug | IHC-64 | 9.02e-05 | 33 | 164 | 4 | CID000162753 | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | 9.08e-05 | 196 | 164 | 8 | 5668_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 2326_DN | |
| Disease | Congenital anosmia | 3.07e-05 | 2 | 164 | 2 | C0393778 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Noonan Syndrome | 3.13e-04 | 24 | 164 | 3 | C0028326 | |
| Disease | Malignant neoplasm of breast | RAD51C FRMPD1 DNAJC21 H2AC21 CTIF APOL1 TERT PARP1 NAA25 NF1 SLC6A5 TENM1 H2AX UTP20 CNGA2 PADI3 | 3.39e-04 | 1074 | 164 | 16 | C0006142 |
| Disease | perinatal necrotizing enterocolitis (is_marker_for) | 6.33e-04 | 7 | 164 | 2 | DOID:8677 (is_marker_for) | |
| Disease | Familial melanoma | 8.41e-04 | 8 | 164 | 2 | cv:C1512419 | |
| Disease | Malignant melanoma of skin | 8.41e-04 | 8 | 164 | 2 | cv:C0151779 | |
| Disease | Melanoma | 8.41e-04 | 8 | 164 | 2 | cv:C0025202 | |
| Disease | advanced glycation end-product measurement | 1.08e-03 | 9 | 164 | 2 | EFO_0007819 | |
| Disease | familial melanoma (is_implicated_in) | 1.08e-03 | 9 | 164 | 2 | DOID:6846 (is_implicated_in) | |
| Disease | hypothyroidism | 1.09e-03 | 284 | 164 | 7 | EFO_0004705 | |
| Disease | Glioma | 1.43e-03 | 87 | 164 | 4 | C0017638 | |
| Disease | Familial Atypical Mole Melanoma Syndrome | 1.63e-03 | 11 | 164 | 2 | C2314896 | |
| Disease | Cognitive impairment | 1.63e-03 | 11 | 164 | 2 | HP_0100543 | |
| Disease | hair color | 1.84e-03 | 311 | 164 | 7 | EFO_0003924 | |
| Disease | PR interval | 1.88e-03 | 495 | 164 | 9 | EFO_0004462 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.89e-03 | 157 | 164 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.95e-03 | 12 | 164 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.02e-03 | 45 | 164 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | matrix metalloproteinase measurement | 2.30e-03 | 13 | 164 | 2 | EFO_0004744 | |
| Disease | Chromosome Breakage | 2.67e-03 | 14 | 164 | 2 | C0376628 | |
| Disease | Chromosome Breaks | 2.67e-03 | 14 | 164 | 2 | C0333704 | |
| Disease | melanoma | 2.71e-03 | 248 | 164 | 6 | C0025202 | |
| Disease | blood copper measurement | 2.73e-03 | 50 | 164 | 3 | EFO_0007578 | |
| Disease | Leukemia, Myelocytic, Acute | 2.87e-03 | 173 | 164 | 5 | C0023467 | |
| Disease | 1,3,7-trimethylurate measurement | 3.07e-03 | 15 | 164 | 2 | EFO_0021172 | |
| Disease | triacylglycerol 52:3 measurement | 3.07e-03 | 15 | 164 | 2 | EFO_0010415 | |
| Disease | RASopathy | 3.07e-03 | 15 | 164 | 2 | cv:C5555857 | |
| Disease | Tremor, Rubral | 3.50e-03 | 16 | 164 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.50e-03 | 16 | 164 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.50e-03 | 16 | 164 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 3.50e-03 | 16 | 164 | 2 | C0240991 | |
| Disease | Abnormal coordination | 3.50e-03 | 16 | 164 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 3.50e-03 | 16 | 164 | 2 | C0427190 | |
| Disease | Pontoneocerebellar hypoplasia | 3.50e-03 | 16 | 164 | 2 | cv:C1261175 | |
| Disease | low density lipoprotein particle size measurement | 4.16e-03 | 58 | 164 | 3 | EFO_0008593 | |
| Disease | Bone marrow hypocellularity | 4.43e-03 | 18 | 164 | 2 | C1855710 | |
| Disease | Brain Ischemia | 4.57e-03 | 60 | 164 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 4.57e-03 | 60 | 164 | 3 | C0917798 | |
| Disease | cutaneous melanoma | 4.72e-03 | 121 | 164 | 4 | EFO_0000389 | |
| Disease | gout | 4.88e-03 | 196 | 164 | 5 | EFO_0004274 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.93e-03 | 19 | 164 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.93e-03 | 19 | 164 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.93e-03 | 19 | 164 | 2 | C1275081 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 4.93e-03 | 19 | 164 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | Costello syndrome (disorder) | 4.93e-03 | 19 | 164 | 2 | C0587248 | |
| Disease | melanoma | 5.45e-03 | 126 | 164 | 4 | EFO_0000756 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 5.48e-03 | 64 | 164 | 3 | DOID:224 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETLHLEYFEEAVNYL | 201 | Q86TX2 | |
| VVAETDYQSFAVLYL | 126 | P07360 | |
| IEELERFIDSYVLEY | 21 | O43310 | |
| ALDDLVTVEEHLYFY | 2341 | Q86UK0 | |
| VHLYLLLVEVFESEY | 946 | O94910 | |
| LLVEVFESEYSRTKY | 951 | O94910 | |
| YLAAVLEYLTAEILE | 51 | P0C0S8 | |
| YLAAVLEYLTAEILE | 51 | Q8IUE6 | |
| SLDLYYTEDEIYELS | 416 | O95267 | |
| YLAAVLEYLTAEILE | 51 | Q7L7L0 | |
| YLAAVLEYLTAEILE | 51 | Q9BTM1 | |
| AAVYSAAILEYLTAE | 51 | Q71UI9 | |
| LEEYFLVNLTYVGLT | 2916 | Q8WXG9 | |
| YFENTDILIYVIDSA | 81 | P36405 | |
| YLDYAIQATETLAFV | 281 | P51679 | |
| ELTTLLLDEYELSIY | 56 | Q5H913 | |
| STYLLAFIVSEFDYV | 276 | P15144 | |
| YLETADYSIREEIVL | 411 | O94973 | |
| TYLQSEEIVAELVYS | 686 | Q7Z4T9 | |
| GASILTILELFDYIY | 441 | Q16515 | |
| LEDFTLDNILSHIYY | 196 | O43502 | |
| ISTLEGLDYEETAFY | 301 | Q9Y5G6 | |
| KTEFAYEYVLLDFTL | 31 | Q52LD8 | |
| VELLYYVEELDSSLI | 161 | P08263 | |
| ADIHLVELFYYVEEL | 156 | Q7RTV2 | |
| VELFYYVEELDSSLI | 161 | Q7RTV2 | |
| YYSLVTDIVLDREQV | 401 | O60330 | |
| DTSLLYNEYIVYDIA | 981 | P09874 | |
| YSILLFDLIYREETL | 2341 | Q14573 | |
| STLFIAYYDHVAVLL | 176 | Q01726 | |
| FSLYTRDVAGLYEEI | 261 | Q7Z304 | |
| LYLQYTDETFRTTIE | 71 | P00450 | |
| IYYDITDVEFELIAS | 306 | Q9H306 | |
| VIEISEYRTQLYEYL | 261 | Q9Y2X3 | |
| TYEIAPVFVLLEYVT | 206 | Q05329 | |
| SSYDVLHLVEFYLEE | 1086 | Q9HBG6 | |
| VTFYDVYIILQAFIL | 116 | Q9HC24 | |
| LVDLADEVASVYQSY | 81 | Q7Z434 | |
| YTLTEELAEYAEIRV | 611 | P20916 | |
| YNEAVYLVRFLSDLV | 121 | Q09161 | |
| YSLLLFDLVYREETL | 2421 | Q14643 | |
| EFTETYLTVLSDSLY | 471 | Q9C0I1 | |
| LTTEDLEAYIYVFSQ | 256 | Q8IUS5 | |
| LYVISSLELLVAEDY | 216 | Q86WG3 | |
| IDRYFYVSIGSIDIV | 1406 | Q5SZK8 | |
| YLTSSIVDEILQELY | 836 | Q8ND23 | |
| IVDSVYYDVLQQYEL | 4046 | Q5CZC0 | |
| LLEEIYDYQVQSLVS | 5061 | Q5CZC0 | |
| LYSATFLEDIIIDLV | 5271 | Q5CZC0 | |
| YVEIYNETVRDLLAT | 461 | Q9BW19 | |
| IYIERLVSYADIDIC | 216 | Q5T2Q4 | |
| VELLYYVEELDSSLI | 161 | P09210 | |
| ADISLVELLYYVEEL | 156 | Q16772 | |
| VELLYYVEELDSSLI | 161 | Q16772 | |
| EISNLYIYDTVLLLA | 321 | O43424 | |
| YLAAVLEYLTAEILE | 51 | P16104 | |
| LIEDYIYESLVEDTY | 1951 | Q9Y6V0 | |
| LYSDLSDALVIFQLY | 416 | P13796 | |
| SFTLENSEEDYYRLL | 391 | Q9Y5G4 | |
| IEYAASVLEAVYIDE | 56 | P54750 | |
| EYTASLLEAVYIDET | 61 | Q01064 | |
| EYAATVLESVYIDET | 66 | Q14123 | |
| VYSEYLEDVLEELTY | 116 | Q9H1Q7 | |
| LFLSELQYYLTTEVH | 41 | Q9Y282 | |
| IAASLLESDYEYEYL | 2006 | O94915 | |
| KLIESELSYFVIVYS | 426 | Q8N4B4 | |
| LSLDLFYTEDEIYEL | 411 | Q8TDF6 | |
| LTFEYYELFVNILVV | 291 | Q5TB30 | |
| ALYRSILDAYIIEFF | 26 | Q96FB5 | |
| YIASLVFLHEFIDVY | 991 | O75110 | |
| TVRVSYLEIYNESLF | 136 | Q9HAQ2 | |
| YLEIYNESLFDLLST | 141 | Q9HAQ2 | |
| VIALIYLASLSEYDQ | 226 | P30679 | |
| AYAVLYLTCVDISLD | 106 | Q9ULW8 | |
| VILVSAGEAYLVYTD | 66 | O43688 | |
| YQDDSLDLLRYFTVT | 81 | Q5F1R6 | |
| SFYEERALYLEAIIQ | 1831 | Q2PPJ7 | |
| DSIYYTLSVIALIVF | 216 | Q9HC58 | |
| RDGLITTVYFYELQE | 236 | Q9Y2H9 | |
| VETLEQYKFVYEVAL | 1421 | O14522 | |
| ELDYETTSHYLFRVI | 1466 | Q6V1P9 | |
| VFYEQYLTIIDDTIF | 1086 | O15118 | |
| TIDKVSVLDYLSYAV | 201 | P13674 | |
| LTISRVLTEDEADYY | 91 | A0A075B6J6 | |
| AIFTLIEEVLFYYSH | 176 | Q96IV6 | |
| VDYEDYQSVTRFLDL | 1621 | Q13535 | |
| VFLSVIEYAAVNYLT | 341 | A8MPY1 | |
| YDDADILTYRITVVE | 556 | Q6WRI0 | |
| IDETALQAIVEYAYT | 81 | Q9NXS3 | |
| AVAEIDALYDVYLDV | 176 | Q92874 | |
| SDEYDILVFDALIYI | 666 | Q92608 | |
| FTEAAYTLLLYDELL | 1216 | Q8N1I0 | |
| SSLLEYYTELDAVVL | 211 | Q9UKA2 | |
| LTEYTIAIFSIYDEG | 596 | Q05707 | |
| IRSIEYFALALEEQY | 216 | Q5SYB0 | |
| DYITYIDELLTYINA | 431 | Q01740 | |
| VSFFLVLDVVYLVYE | 341 | O14791 | |
| EDFERTVLTLAYTAY | 121 | Q6UWF9 | |
| AAVYSAAILEYLTAE | 51 | P0C0S5 | |
| VYFVASVAVLYSVEE | 81 | O95834 | |
| LKDDYDYVLISSVLF | 956 | Q8N766 | |
| YLAAVLEYLTAEILE | 51 | Q96QV6 | |
| YLAAVLEYLTAEILE | 51 | P04908 | |
| YLAAVLEYLTAEILE | 51 | Q93077 | |
| YLAAVLEYLTAEILE | 51 | P20671 | |
| YLAAVLEYLTAEILE | 51 | Q96KK5 | |
| YLAAVLEYLTAEILE | 51 | Q99878 | |
| LEEFLSVRTLYFIAY | 631 | Q9Y2W3 | |
| GDEYEIYRIIFDITF | 4836 | Q92736 | |
| LLLSQFREYLDYDDT | 166 | Q9BVI4 | |
| FLLYVDTDYLDSISE | 271 | Q9BXJ2 | |
| VRLFQDEEIYSDLYL | 126 | Q66K64 | |
| TFLSTIEAIYYFLVD | 246 | Q8N5C7 | |
| SIEIDSLYEGIDFYT | 281 | P11142 | |
| ALNYYILTDELFLAL | 236 | Q9UKT6 | |
| LAEDYTLLDVLYYVT | 1331 | Q99683 | |
| YYIVDEDSTFLEVTL | 1781 | P0C091 | |
| VLLAYAEEDIYDTSR | 2206 | O75691 | |
| VLAYLYEIRTSFQEF | 1056 | Q9C093 | |
| NEESLYYIEELIFQL | 41 | Q07890 | |
| VSLYIVAVLEYISAD | 126 | Q07890 | |
| ISISLAELAVFIYYA | 76 | Q9NX52 | |
| ESDLDYIQYRLEYEI | 16 | Q8WVK7 | |
| VDTELLAERFYYQAL | 191 | Q9UPR3 | |
| LVDTYAASYALVIIA | 631 | Q9Y345 | |
| TLISAAREYEIEFIY | 121 | O60502 | |
| EDRTESALSYYEFLL | 1071 | O95486 | |
| AVEEDTFEVYLYVTI | 176 | Q587J7 | |
| VSESVFQLLVDYIYH | 91 | Q9NVX7 | |
| LVASYYEDYAAELVV | 56 | Q8WXC3 | |
| TLDQYVESDYTLLYL | 111 | Q07960 | |
| RVVDFTILTEAVYSY | 601 | Q86V20 | |
| LLVFLLAYAAYLTAE | 281 | Q14940 | |
| YFVLSVEQYLELSDS | 2696 | Q9UKZ4 | |
| YIFEYDSSDRLLAVT | 1951 | Q9NT68 | |
| SIDTYERDLYLSVQF | 1731 | P14410 | |
| VSVYIVAVLEYISAD | 126 | Q07889 | |
| TYLFDLDYVEDVYTV | 296 | O43463 | |
| SILTVLELFDYAYEV | 446 | P78348 | |
| EDFLDSQITTVDLYY | 21 | Q6V702 | |
| LVLDYVSDVVYIADL | 176 | Q16280 | |
| LDYSADVLYVLDVLV | 206 | Q16281 | |
| VYFIITLSDLECDYI | 21 | Q9P003 | |
| YAYTESELQIALIAL | 316 | Q92759 | |
| LYAEENAIEDTIFYL | 331 | Q99816 | |
| FSVRYYLNLVLIDEE | 266 | Q4G0F5 | |
| LAYLAYETVAQLVDL | 221 | O75486 | |
| EIFLLIIVAYDRYVA | 111 | Q8NGC2 | |
| RYLEFYVLESKLTEF | 616 | Q9Y5W7 | |
| VDYLLRLQESISDFY | 3771 | Q15413 | |
| IEYVFTVIYTFEALI | 156 | Q9Y5Y9 | |
| VTVFYLVAYAAVDLS | 421 | Q9BXP2 | |
| VLYTYAASEDVAALE | 1361 | Q6ZV73 | |
| SSFSDELYVDVTYIV | 111 | P16471 | |
| QRILYEYLAEASVVF | 2636 | P21359 | |
| TLTDVDDLIFKLAYY | 3371 | Q709C8 | |
| LLTYELYEKFTEAVS | 106 | Q2M1Z3 | |
| GLYYLAELIEEYTVA | 26 | Q6UWH6 | |
| STSYEEQELLRLIYY | 601 | Q2NKQ1 | |
| VDLTEIYGERLYETS | 206 | Q9UKN8 | |
| VLYYADALTEIAFVV | 1251 | Q86X10 | |
| VFIFYYVVEEILELH | 361 | Q9P0L9 | |
| AAEEYETALTVLDTY | 286 | Q8NA56 | |
| IASEIFLTAEESLYY | 336 | Q6XPS3 | |
| LVTENLALTEYTLYL | 506 | Q14139 | |
| IDSYLEKQVVTFLDY | 66 | Q6P3X3 | |
| ELDDLEYIYDLFSVI | 281 | Q9NVE5 | |
| DATQVYVAFLVYLDL | 56 | Q8WW01 | |
| VYVVELLRSFFYVTE | 551 | O14746 | |
| SVVAAEYELEYLLLE | 1101 | Q9NYU2 | |
| FVALYDYEARTTEDL | 96 | P07947 | |
| YFDAILIGAYTTLLD | 1006 | P35573 | |
| YTYIAEEDVLDQTLS | 921 | O94898 | |
| YLTYFDSVFRLIEEA | 266 | Q14CX7 |